Browse Category

Investment Forecasts News 3 December 2025 - 8 December 2025

Canaan Inc (CAN) Stock: BTIG Buy Rating, Green Bitcoin Pivot and 2026 Forecasts — December 8, 2025

Canaan Inc (CAN) Stock: BTIG Buy Rating, Green Bitcoin Pivot and 2026 Forecasts — December 8, 2025

Canaan Inc. (NASDAQ: CAN), the Bitcoin mining hardware maker turned vertically integrated miner, is back in the spotlight on December 8, 2025 after BTIG launched coverage with a Buy rating and a $3.00 price target, implying several hundred percent upside from where the stock trades today. Investing At the same time, Canaan’s fundamentals have sharply improved, its energy strategy is…
Genting Singapore (SGX:G13) on 8 December 2025: Share Price, Q3 2025 Results, RWS 2.0 Expansion and 2026 Forecasts

Genting Singapore (SGX:G13) on 8 December 2025: Share Price, Q3 2025 Results, RWS 2.0 Expansion and 2026 Forecasts

Genting Singapore Limited, the operator of Resorts World Sentosa (RWS) and a heavyweight on the Straits Times Index, is in an interesting spot on 8 December 2025: fundamentals and tourism recovery are improving, yet the share price is still treading water near the lower end of analyst target ranges. Beansprout This article rounds up the latest news, forecasts and analyses…
Nebius Group NV (NBIS) Stock on December 6, 2025: Price, Microsoft & Meta Megadeals, Q3 Results and 2026 Forecasts

Nebius Group NV (NBIS) Stock on December 6, 2025: Price, Microsoft & Meta Megadeals, Q3 Results and 2026 Forecasts

Nebius Group N.V. (NASDAQ: NBIS) has quickly become one of the most talked‑about names in the AI infrastructure “neocloud” trade. As of December 6, 2025, the stock is well off its October peak but still massively ahead of where it started the year, with investors trying to decide whether the latest pullback is a buying opportunity or a warning sign.…
National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank Limited (ASX:NAB) shares are trading around A$40.6–A$40.7 on Friday, 5 December 2025, nudging higher after a volatile November as investors weigh a solid dividend stream against slower profit growth and a richer valuation multiple. StockAnalysis According to live market data, NAB was recently quoted at A$40.64, up about 0.3–0.4% on the day, with an intraday range of…
Praxis Precision Medicines (PRAX) Stock Surges on FDA Progress and Epilepsy Trial Wins: Latest News and 2026 Forecast

Praxis Precision Medicines (PRAX) Stock Surges on FDA Progress and Epilepsy Trial Wins: Latest News and 2026 Forecast

Updated December 5, 2025 – all developments since December 4, 2025 Praxis Precision Medicines, Inc. (NASDAQ: PRAX) has moved back into the market spotlight after a flurry of major announcements on December 4, 2025. The biotech’s stock — already one of 2025’s wildest movers — is reacting to fresh positive data in rare epilepsies and new regulatory momentum for its…
Rigetti Computing (RGTI) Stock on December 4, 2025: Q3 Earnings Shock, Quantum Roadmap and 2026–2027 Forecasts

Rigetti Computing (RGTI) Stock on December 4, 2025: Q3 Earnings Shock, Quantum Roadmap and 2026–2027 Forecasts

Rigetti Computing, Inc. (NASDAQ: RGTI) remains one of 2025’s wildest stories in quantum computing and in the broader U.S. stock market. After rocketing from penny‑stock territory in 2023 to a 2025 high above $58, the stock has just endured a brutal November sell‑off tied to Q3 2025 earnings, even as the company doubles down on an aggressive roadmap toward 1,000+…
Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare (IXHL) Stock Soars on FDA Fast Track: December 2025 Outlook, Forecast & Key Risks

Incannex Healthcare Inc. (Nasdaq: IXHL) is back on traders’ radar after the U.S. Food and Drug Administration granted Fast Track designation to its lead sleep-apnoea drug candidate, IHL‑42X. The move caps a busy 2025 that also brought strong Phase 2 data in sleep apnoea and psilocybin-assisted therapy, a major clean-up of warrant overhang, and a fight to keep the company’s…
Robinhood Stock (HOOD) Jumps on Crypto Rebound: Latest News, Earnings Beat and 2026 Forecast – 4 December 2025

Robinhood Stock (HOOD) Jumps on Crypto Rebound: Latest News, Earnings Beat and 2026 Forecast – 4 December 2025

Robinhood Markets, Inc. (NASDAQ: HOOD) is back in the spotlight. On Thursday, 4 December 2025, HOOD is trading around $133–134 per share, up roughly 6% on the day, after another crypto‑driven surge in trading activity. That puts Robinhood’s market value near $120 billion and leaves the stock only about 13–18% below its October all‑time high, while still hundreds of percent…
Marvell Technology (MRVL) Soars on Celestial AI Deal: Latest Earnings, Analyst Upgrades and 2026 Stock Forecast

Marvell Technology (MRVL) Soars on Celestial AI Deal: Latest Earnings, Analyst Upgrades and 2026 Stock Forecast

Updated: December 4, 2025 Marvell Technology, Inc. (NASDAQ: MRVL) is back in the market spotlight. The AI‑focused chip designer has just delivered record quarterly results, unveiled a $3.25 billion acquisition of photonics startup Celestial AI, and triggered a wave of bullish analyst upgrades. As of midday on December 4, 2025, Marvell shares are trading around $100 per share, up roughly…
Pro Medicus (ASX: PME) Share Price Update: Data Breach Explained, New US Contracts and 2026 Stock Forecast

Pro Medicus (ASX: PME) Share Price Update: Data Breach Explained, New US Contracts and 2026 Stock Forecast

Published: 4 December 2025 Pro Medicus share price today Pro Medicus Limited (ASX: PME), the $27‑billion Australian healthcare imaging software group, is trading around A$253–255 per share in Thursday trade, slightly lower on the session after the company confirmed details of an isolated cybersecurity incident. Investing.com Nigeria Over the past 12 months, PME has traded between roughly A$162 and A$336,…
CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

CSL Limited (ASX:CSL) Share Price on 4 December 2025: Restructuring Fallout, New Vaccine Plant and 2026 Stock Forecast

Updated: 4 December 2025 CSL Limited (ASX:CSL), the Australian biotech heavyweight, is trading around A$183 per share on 4 December 2025 after one of the most bruising years in its modern history. The company has delivered solid profit growth, announced thousands of job cuts, delayed a major spin‑off, launched a A$750 million buy‑back and opened a A$1 billion cell‑based vaccine…
Amphenol Corporation (APH) Stock on December 3, 2025: AI Datacenter Deals, Insider Sales and Wall Street Forecasts

Amphenol Corporation (APH) Stock on December 3, 2025: AI Datacenter Deals, Insider Sales and Wall Street Forecasts

Amphenol Corporation (NYSE: APH) remains one of the standout performers in large-cap technology hardware as of December 3, 2025, powered by the AI datacenter boom, aggressive M&A and strong institutional demand – but also carrying a valuation that many analysts now describe as “stretched.” Below is a detailed look at where Amphenol stock stands today, the most important news and…

Stock Market Today

  • Mukesh Ambani and BlackRock CEO Urge Indians to Choose Equities Over Gold
    February 5, 2026, 2:23 AM EST. Indian billionaire Mukesh Ambani and BlackRock CEO Larry Fink encouraged Indians to invest in equities rather than gold amid volatility in the metal and subdued stock market performance. Gold and real estate still dominate Indian household assets, comprising nearly 59% in fiscal year 2025. However, growing financialization is evident as mutual fund assets are rising, with Bain & Company forecasting retail mutual fund assets to reach $3.3 trillion by 2035, up from $600 billion in 2025. Ambani called physical assets "unproductive" compared to stock market returns. Fink highlighted India's projected 6.4% growth in 2026 and predicted Indian stocks could multiply in value over the next two decades, urging Indians to invest in the country's expanding capital markets to share in its growth.
Go toTop